Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Blue Ivy Ventures is a venture capital firm founded in 2014 and operates as an affiliate of Alumni Ventures. Based in the United States, the firm primarily serves accredited investors, particularly those connected to Yale University, by providing access to venture capital investments that are typically reserved for institutional investors. The firm aims to democratize venture investing, allowing a broader range of investors to participate in high-quality deals.
As part of Alumni Ventures, Blue Ivy Ventures benefits from a significant infrastructure and a vast network of over 11,000 accredited investors. This affiliation enhances its reach and resources, enabling the firm to support innovative ventures across various sectors, including technology, healthcare, and climate tech. Blue Ivy Ventures has deployed a total of $1.4 billion across more than 1,400 companies, showcasing its commitment to diversifying its investment portfolio.
The firm has built a portfolio of approximately 30 companies, focusing on sectors such as healthcare, AI, consumer products, and climate solutions. Blue Ivy Ventures emphasizes collaboration with leading venture capital firms to access high-quality deals and provide tailored support to its portfolio companies through its extensive alumni network.
Blue Ivy Ventures invests across multiple sectors, including healthcare, artificial intelligence, consumer products, and climate technology. The firm targets various stages of company development, from pre-seed and seed rounds to Series A, Series B, and growth equity investments. Check sizes range from $100,000 to $10 million, with a typical sweet spot between $1 million and $3 million. This flexibility allows Blue Ivy Ventures to engage with startups at different growth phases, providing essential capital as they scale.
The firm’s investment strategy is heavily influenced by its connection to the Yale alumni community. Blue Ivy Ventures leverages this network to source and support venture-backed companies, often co-investing alongside established lead firms. This collaborative approach not only enhances deal quality but also provides portfolio companies with access to valuable resources, including customers, talent, and advisors. The firm’s commitment to supporting its portfolio extends beyond capital, as it offers educational resources and events to empower both investors and founders.
Blue Ivy Ventures has invested in a diverse array of companies, totaling around 30 in its portfolio. Notable companies include:
In addition to these, Blue Ivy Ventures has also backed companies like Sygaldry Technologies, Glydways, Wasabi Technologies, Function Health, Elion Health, and Runwise, showcasing its commitment to investing in high-potential startups across various sectors.
Michael Collins: Chief Executive Officer and Board Chairman, brings extensive experience in venture capital and entrepreneurship.
James Gill: Co-Founder & Lead Director, has a strong background in investment management and startup development.
Errik Anderson: Board Director, specializes in technology investments and has a history of successful venture-backed exits.
Matt Blumberg: Board Director, known for his expertise in scaling startups and operational management.
Laura Bordewieck Rippy: Board Director, focuses on healthcare investments and has a background in medical technology.
Ludwig Pierre Schulze: Board Director, brings experience in international investments and market expansion strategies.
Michael Phillips: Board Secretary, has a background in legal and compliance matters within the venture capital space.
Mark Edwards: Executive Team member, known for his operational support and strategic guidance to portfolio companies.
To pitch Blue Ivy Ventures, founders should use the application portal available at this link or email info@av.vc. The firm prefers pitches that include a credible lead investor already secured in the round. Founders should include a clear overview of their business model, market opportunity, and team qualifications in their pitch deck.
Response times can vary, but founders are encouraged to submit their applications as soon as they have a lead investor. Blue Ivy Ventures operates on a rolling application cycle, allowing for flexibility in submissions. Warm introductions through the Yale alumni network can enhance the chances of a successful pitch.
Blue Ivy Ventures offers several programs designed to enhance the experience of its investors and portfolio companies. The Diamond Club is a loyalty program for engaged investors, providing exclusive benefits and access to special investment opportunities.
The Concierge Services program offers tailored support for investors allocating significant capital to venture, ensuring curated deal flow and institutional-grade diligence. Additionally, the NextGen Family Office Club is aimed at emerging family office leaders, providing education in venture investing through real deals and mentorship.
Lastly, the Venture Fellow Program is a year-long initiative designed to educate and empower diverse individuals to launch careers in venture capital, further expanding the reach and impact of Blue Ivy Ventures within the investment community.
In recent months, Blue Ivy Ventures has made significant strides in its investment activities. The firm has participated in funding rounds for several notable companies, including Elion Health, which raised $9.3 million in a seed round with Alumni Ventures' participation.
Additionally, Blue Ivy Ventures has been recognized in various industry rankings, including being named one of the Top 20 US VCs by Time in 2025 and featured in CB Insights' Top 20 Venture Firms in 2024. The firm has also been acknowledged by Inc. as one of the Most Founder Friendly Investors in 2024.
Blue Ivy Ventures continues to engage with its community through upcoming events, such as the Oxford Alumni: Celebrating Entrepreneurship on April 30, 2026, in New York, NY, and the Marketing Robotics in Real Time event on May 7, 2026, also in New York, NY.
What are Blue Ivy Ventures' investment criteria?
Blue Ivy Ventures focuses on investing in startups across various sectors, including healthcare, AI, consumer products, and climate technology. They typically invest at pre-seed, seed, Series A, and Series B stages, with check sizes ranging from $100,000 to $10 million.
How can I pitch to Blue Ivy Ventures?
Founders can pitch to Blue Ivy Ventures through their application portal at this link or by emailing info@av.vc. The firm prefers pitches that include a credible lead investor already secured in the round.
What makes Blue Ivy Ventures different from other VCs?
Blue Ivy Ventures is unique in its focus on the Yale alumni community, leveraging this network to source and support investments. The firm operates as a co-investor, meaning it does not lead rounds or set terms, which allows it to collaborate with established lead firms.
What is the geographic scope of Blue Ivy Ventures?
The firm invests globally, with a particular emphasis on opportunities within the United States. This broad geographic focus allows Blue Ivy Ventures to tap into diverse markets and innovative startups.
What kind of support do portfolio companies receive?
Blue Ivy Ventures provides tailored support through its extensive alumni network, offering access to customers, talent, advisors, and distribution channels. Additionally, the firm hosts educational resources and events to empower its investors and portfolio companies.
What is the decision timeline for investments?
The decision timeline for investments is not publicly disclosed, but Blue Ivy Ventures operates on a rolling application cycle. Founders are encouraged to submit their pitches as soon as they have a lead investor secured.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.